Original Article
Neuropsychopharmacology (2009) 34, 2265–2274; doi:10.1038/npp.2009.53; published online 3 June 2009
Profound Changes in Dopaminergic Neurotransmission in the Prefrontal Cortex in Response to Flattening of the Diurnal Glucocorticoid Rhythm: Implications for Bipolar Disorder
Gareth O Minton1, Allan H Young2, Richard McQuade1, Graeme Fairchild3, Colin D Ingram1 and Sarah E Gartside1
- 1Psychobiology Research Group, Institute of Neuroscience, Newcastle University, Framlington Place, Newcastle upon Tyne, UK
- 2Department of Psychiatry, Institute of Mental Health, University of British Columbia, Vancouver, British Columbia, Canada
- 3Developmental Psychiatry Section, Department of Psychiatry, Cambridge University, Cambridge, UK
Correspondence: Dr SE Gartside, Psychobiology Research Group, Newcastle University, The Medical School, Framlington Place, Newcastle upon Tyne, Tyne and Wear, NE2 4HH, UK. Tel: +44 191 222 7633; Fax: +44 191 222 5227; E-mail: sasha.gartside@ncl.ac.uk
Received 19 December 2008; Revised 20 April 2009; Accepted 22 April 2009; Published online 3 June 2009.
Abstract
Patients with bipolar disorder have abnormalities in glucocorticoid secretion, dopaminergic neurotransmission, and prefrontal cortical function. We hypothesized that the flattening of the diurnal glucocorticoid rhythm, commonly seen in bipolar disorder, modulates dopaminergic neurotransmission in the prefrontal cortex (PFC) leading to abnormalities in prefrontally mediated neurocognitive functions. To address this hypothesis, we investigated the effects of a flattened glucocorticoid rhythm on (i) the release of dopamine in the PFC and (ii) the transcription of genes in the ventral tegmental area (VTA) coding for proteins involved in presynaptic aspects of dopaminergic neurotransmission. Male rats were treated for 13–15 days with corticosterone (50
g/ml in the drinking water) or vehicle (0.5% ethanol). Corticosterone treatment resulted in marked adrenal atrophy and flattening of the glucocorticoid rhythm as measured by repeated blood sampling. Animals treated with corticosterone showed markedly enhanced basal dopamine release in the PFC as measured by microdialysis in the presence of a dopamine reuptake inhibitor. Depolarization-evoked release was also enhanced, suggesting that the corticosterone effect on basal release did not result from an increase in the neuronal firing rate. Local blockade of terminal D2 autoreceptors failed to normalize release to control values, suggesting that the enhanced release was not because of reduced autoreceptor sensitivity. In situ hybridization histochemistry showed that mRNAs coding tyrosine hydroxylase and the vesicular monoamine transporter 2 were elevated in the VTA of corticosterone-treated rats. Our data show that flattening of the glucocorticoid rhythm increases dopamine release in the PFC possibly as a result of increased synthesis and vesicular storage. This provides a mechanistic explanation for prefrontal dysfunction in bipolar and other affective disorders associated with glucocorticoid dysrhythmia.
Keywords:
dopamine, ventral tegmental area, microdialysis, in situ hybridization histochemistry, HPA axis, corticosteroid, corticosterone
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
REVIEWS
Modafinil: A Review of Neurochemical Actions and Effects on Cognition
Neuropsychopharmacology Perspective
RESEARCH
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article
Neuropsychopharmacology Original Article

